Reasons for success and lessons learnt from nanoscale vaccines against COVID-19

Nat Nanotechnol. 2021 Aug;16(8):843-850. doi: 10.1038/s41565-021-00946-9.

Thomas Kisby^#^{1

2}, Açelya Yilmazer^#^{3

4}, Kostas Kostarelos^{5

6

7}

¹ Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.
² National Graphene Institute, University of Manchester, Manchester, UK.
³ Stem Cell Institute, Ankara University, Ankara, Turkey.
⁴ Department of Biomedical Engineering, Ankara University, Ankara, Turkey.
⁵ Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK. kostas.kostarelos@manchester.ac.uk.
⁶ National Graphene Institute, University of Manchester, Manchester, UK. kostas.kostarelos@manchester.ac.uk.
⁷ Catalan Institute of Nanoscience and Nanotechnology (ICN2), UAB Campus Bellaterra, Barcelona, Spain. kostas.kostarelos@manchester.ac.uk.

^# Contributed equally.

No abstract available

Publication types